CI
EW icon

Conning Inc’s Edwards Lifesciences EW Stock Holding History

Conning Inc’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$221K Sell
2,765
-425
-13% -$35K 0.01% 296
2025
Q4 		$272K Buy
3,190
+48
+2% +$3.94K 0.01% 299
2025
Q3 		$244K Hold
3,142
– – 0.01% 320
2025
Q2 		$246K Sell
3,142
-150
-5% -$11.2K 0.01% 319
2025
Q1 		$239K Sell
3,292
-1,148
-26% -$82.2K 0.01% 321
2024
Q4 		$329K Sell
4,440
-303
-6% -$21.2K 0.01% 279
2024
Q3 		$313K Sell
4,743
-26
-0.5% -$1.89K 0.01% 291
2024
Q2 		$441K Buy
4,769
+278
+6% +$24.6K 0.02% 236
2024
Q1 		$429K Sell
4,491
-180
-4% -$15.1K 0.01% 242
2023
Q4 		$356K Buy
4,671
+30
+0.6% +$2.09K 0.01% 256
2023
Q3 		$322K Sell
4,641
-80
-2% -$6.43K 0.01% 258
2023
Q2 		$445K Sell
4,721
-430
-8% -$37.4K 0.01% 231
2023
Q1 		$426K Sell
5,151
-37
-0.7% -$2.91K 0.01% 247
2022
Q4 		$387K Sell
5,188
-15
-0.3% -$1.16K 0.01% 265
2022
Q3 		$430K Sell
5,203
-925
-15% -$89K 0.02% 242
2022
Q2 		$583K Sell
6,128
-51
-0.8% -$5.28K 0.02% 228
2022
Q1 		$727K Sell
6,179
-200
-3% -$22.4K 0.02% 218
2021
Q4 		$826K Sell
6,379
-6,006
-48% -$701K 0.02% 201
2021
Q3 		$1.4M Buy
12,385
+4,555
+58% +$520K 0.04% 172
2021
Q2 		$811K Sell
7,830
-736
-9% -$69.4K 0.02% 211
2021
Q1 		$716K Sell
8,566
-720
-8% -$60.9K 0.02% 229
2020
Q4 		$847K Sell
9,286
-459
-5% -$38.1K 0.03% 217
2020
Q3 		$778K Buy
9,745
+121
+1% +$9.44K 0.03% 216
2020
Q2 		$665K Sell
9,624
-588
-6% -$41.8K 0.02% 232
2020
Q1 		$642K Sell
10,212
-6
-0.1% -$433 0.03% 219
2019
Q4 		$795K Sell
10,218
-390
-4% -$30.5K 0.03% 235
2019
Q3 		$778K Buy
10,608
+330
+3% +$23.2K 0.03% 247
2019
Q2 		$633K Sell
10,278
-1,770
-15% -$107K 0.02% 271
2019
Q1 		$768K Sell
12,048
-30
-0.2% -$1.71K 0.02% 280
2018
Q4 		$617K Sell
12,078
-1,500
-11% -$75.9K 0.02% 298
2018
Q3 		$788K Sell
13,578
-870
-6% -$42.5K 0.02% 302
2018
Q2 		$701K Sell
14,448
-630
-4% -$29.4K 0.02% 328
2018
Q1 		$701K Sell
15,078
-30
-0.2% -$1.3K 0.02% 320
2017
Q4 		$568K Sell
15,108
-240
-2% -$8.81K 0.02% 384
2017
Q3 		$559K Sell
15,348
-240
-2% -$9.15K 0.02% 375
2017
Q2 		$614K Buy
15,588
+30
+0.2% +$1.09K 0.02% 359
2017
Q1 		$488K Sell
15,558
-360
-2% -$11.3K 0.02% 408
2016
Q4 		$497K Hold
15,918
– – 0.02% 386
2016
Q3 		$640K Buy
15,918
+150
+1% +$5.65K 0.03% 337
2016
Q2 		$524K Buy
15,768
+30
+0.2% +$1.03K 0.02% 368
2016
Q1 		$463K Sell
15,738
-300
-2% -$8.28K 0.02% 377
2015
Q4 		$422K Sell
16,038
-900
-5% -$23.4K 0.02% 400
2015
Q3 		$401K Sell
16,938
-1,200
-7% -$29K 0.02% 392
2015
Q2 		$431K Sell
18,138
-180
-1% -$4.06K 0.02% 415
2015
Q1 		$435K Buy
18,318
+60
+0.3% +$1.35K 0.02% 414
2014
Q4 		$388K Sell
18,258
-120
-0.7% -$2.41K 0.02% 431
2014
Q3 		$313K Buy
18,378
+1,920
+12% +$30.3K 0.02% 466
2014
Q2 		$235K Buy
16,458
+18
+0.1% +$244 0.01% 532
2014
Q1 		$203K Buy
+16,440
New +$190K 0.01% 546

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Conning Inc's EW Position: Q1 2026 in Review

Conning Inc reduced its Edwards Lifesciences (EW) stake by 13% in Q1 2026, selling an estimated $35K and leaving 2,765 shares worth $221K. The position accounts for 0.01% of the portfolio, ranked #296.

Conning Inc first reported a position in EW in Q1 2014 and has held it in 49 quarters since. The position peaked at $1.4M in Q3 2021. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Conning Inc held 2,765 shares of Edwards Lifesciences worth $221K as of Q1 2026.
  • Conning Inc sold 425 Edwards Lifesciences shares in Q1 2026, an estimated $35K.
  • Edwards Lifesciences made up 0.01% of Conning Inc's portfolio in Q1 2026, its #296 holding.
  • Conning Inc first reported a position in Edwards Lifesciences in Q1 2014 and has held it in 49 quarters since.
  • Conning Inc's Edwards Lifesciences position peaked at $1.4M in Q3 2021.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Conning Inc's 13F filing for Q1 2026, filed 30 Apr 2026.